immune system
• mice exhibit severely impaired migration of CCR10+ lymphocytes into the skin; in vivo migration assays show significantly lower total numbers and percentages of donor cells that express CCR10(EGFP)+ in the skin, but not in the spleen, of recipient mice
|
• mice show overactivation of IL-17-producing skin T cells in response to topical imiquimod (IMQ) stimulation
|
• in response to topical IMQ stimulation, IMQ-treated ears show more severe psoriasis-like skin inflammation with increased epidermal thickness and significantly higher percentages of IL-17A+ total, gamma-delta, CD8+ and CD4+ T cells than similarly treated control ears
|
integument
• in response to topical IMQ stimulation, IMQ-treated ears show more severe psoriasis-like skin inflammation with increased epidermal thickness and significantly higher percentages of IL-17A+ total, gamma-delta, CD8+ and CD4+ T cells than similarly treated control ears
|
cellular
• mice exhibit severely impaired migration of CCR10+ lymphocytes into the skin; in vivo migration assays show significantly lower total numbers and percentages of donor cells that express CCR10(EGFP)+ in the skin, but not in the spleen, of recipient mice
|
hematopoietic system
• mice exhibit severely impaired migration of CCR10+ lymphocytes into the skin; in vivo migration assays show significantly lower total numbers and percentages of donor cells that express CCR10(EGFP)+ in the skin, but not in the spleen, of recipient mice
|